Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 146
Oncology Drugs 140
Drug Discovery 71
Clinical Trials 69
Gastrointestinal Drugs 65
Alzheimer's Disease Drugs 37
Liver Cancer Drugs 34
Musculoskeletal Disorders Drugs 32
Pharmaceuticals 30
Infectious Diseases Drugs 29
Brain Cancer Drugs 29
Immune Disorders Drugs 26
Leukemia Drugs 23
Cardiovascular Drugs 22
Breast Cancer Drugs 20
Biopharmaceuticals 19
Kidney Cancer Drugs 17
Lymphoma Drugs 16
Endocrine and Metabolic Disorders Drugs 14
Skin Cancer Drugs 13
Infusions and Injectables 12
Thyroid Cancer Drugs 12
Pharmaceutical Manufacturing 12
Colon Cancer Drugs 11
Anesthetic Drugs 11
Lung Cancer Drugs 10
Drug Delivery 10
Liver and Kidney Disorders Drugs 10
Drugs by Therapeutic Area 9
Bladder Cancer Drugs 9
Analgesics 9
Hematological Drugs 9
Uterine Cancer Drugs 9
Ovarian Cancer Drugs 8
Over the Counter (OTC) Drugs 8
Vitamins and Dietary Supplements 8
Anti-Obesity Drugs 7
Respiratory Drugs 6
Dermatological Drugs 6
Company Reports 5
Pharmaceutical Intermediates 5
Optical Disorders Drugs 4
Mental Disorders Drugs 4
Cervical Cancer Drugs 3
Pancreatic Cancer Drugs 3
Sexual and Reproductive Health Drugs 3
Prostate Cancer Drugs 2
Biosimilars and Biosuperiors 2
Psoriasis Drugs 2
Immunosuppressive Drugs 2
Diabetes Drugs 1
Generic Drugs 1
Pharmacoeconomics 1
Vaccines 1
Allergy Drugs 1
Urological Disorders Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

842 Results (Page 8 of 43)
- Relevance
  Sort by

Drug Development in Rare Diseases: Focus on Clinical Trials and the Regulatory Landscape

 Report
January 2021
Global

From

€955EUR$988USD£806GBP

€1910EUR$1,975USD£1,612GBP

Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028

 Report
February 2023
244 Pages
Global

From

€3249EUR$3,360USD£2,742GBP

€4061EUR$4,200USD£3,428GBP

Global Liver Cancer Therapeutics Market, by Cancer Type, by Therapy, by Equipment, by Age, by Factors, by Route of Administration, by Distribution channel, by Region, Competition, Forecast & Opportunities, 2025

 Report
August 2020
Global

From

€4738EUR$4,900USD£3,999GBP

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1699 Pages
Global

From

€2417EUR$2,500USD£2,040GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1934EUR$2,000USD£1,632GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global Neurology Clinical Trials Market Report and Forecast 2024-2032

 Report
October 2023
140 Pages
Global

From

€2900EUR$2,999USD£2,447GBP

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2417EUR$2,500USD£2,040GBP

Neurology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
118 Pages
Global

From

€4593EUR$4,750USD£3,876GBP

Latin America Liver Cancer Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

 Report
August 2020
80 Pages
Latin America

From

€3626EUR$3,750USD£3,060GBP

Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
99 Pages
Global

From

€3500EUR$3,877USD£3,057GBP

Alzheimer's Disease Drugs - Global Strategic Business Report

 Report
May 2024
93 Pages
Global

From

€5415EUR$5,600USD£4,570GBP

Kidney Cancer Drugs - Global Strategic Business Report

 Report
May 2024
148 Pages
Global

From

€5270EUR$5,450USD£4,448GBP

Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)

 Report
October 2022
200 Pages
Global

From

€2321EUR$2,400USD£1,959GBP

Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
103 Pages
Global

From

€5753EUR$5,950USD£4,856GBP

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2020

 Clinical Trials
March 2020
386 Pages
Global

From

€2417EUR$2,500USD£2,040GBP

Acute pancreatitis - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1209EUR$1,250USD£1,020GBP

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
83 Pages
Global

From

€3384EUR$3,500USD£2,856GBP

Anti-Migraine Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
99 Pages
Global

From

€3500EUR$3,877USD£3,057GBP

United States Endometrial Cancer Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3384EUR$3,500USD£2,856GBP

Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1209EUR$1,250USD£1,020GBP

842 Results (Page 8 of 43)
- 1
- 6
- 7
- 8
- 9
- 10

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.